3 Steps For Managing Innovative Therapies Sponsored Solution - September 15, 2020 Practice Efficiency Policies & Procedures Sign in to save Innovative therapies are bringing new possibilities and hope for populations with rare neuromuscular disease. However, these important advances also come with cost and administrative challenges. To address these challenges and opportunities, an expert panel on management of innovative treatments was recently held in Atlanta, Georgia. The expert panel included a range of clinical and administrative specialists that gathered to develop recommendations for proactive measures health systems can implement now to optimize the management of high-cost, novel agents in rare neuromuscular disease. Based on the opinions of the expert panel, this paper identifies a multifaceted approach, outlining actionable ways to improve the management of innovative therapies across multiple disease states today — and for the future. This approach encourages healthcare organizations to: Build a business case to gain leadership buy-in to provide cutting-edge care in the neuromuscular space Optimize access for the development of standard operating procedures (SOPs) to align with payer criteria and national guidelines for innovative treatments; and Ensure sustainability by creating a long-term, cost-effective model that can expand to other therapeutic areas The sooner health systems can align with their organizations in managing the clinical, financial, operational and legal aspects of high-cost therapies for neuromuscular disease — and commit to the necessary steps to move forward — the better for patients, caregivers, providers and the entire health system.